Top Marijuana Penny Stocks to Watch This Week as Legalization Momentum Builds
The U.S. cannabis industry continues to grow despite market challenges. In 2024, legal cannabis sales reached over $28 billion nationwide. Analysts project that sales could exceed $40 billion annually by 2030, driven by the expansion of adult-use markets and strong consumer demand. Recently, U.S. lawmakers have revisited proposals for banking reform, which could provide cannabis companies with improved access to capital. Additionally, discussions about federal rescheduling have created optimism for multi-state operators and smaller penny stock companies alike. Investors are closely watching these developments, as even small policy shifts may significantly affect valuations. Marijuana penny stocks, often more volatile, provide unique opportunities when momentum builds.
However, trading penny stocks requires caution and a disciplined approach. Technical analysis is especially important in this sector. Traders frequently monitor support and resistance levels, moving averages, and trading volume to confirm their positions. Risk management also plays a crucial role, particularly with speculative cannabis equities. Setting clear stop-loss levels helps protect capital during rapid swings. Meanwhile, diversifying positions reduces exposure to sudden downturns. As legalization headlines continue to shape sentiment, savvy investors utilize both technical setups and risk controls. With proper strategies, marijuana penny stocks may offer short-term gains while balancing long-term industry potential.
The U.S. cannabis market remains one of the most closely watched industries in 2025. Investors are increasingly drawn to companies that combine strong retail networks, efficient cultivation, and improving financial performance. While challenges such as federal prohibition, high taxation, and pricing pressure persist, leading operators are demonstrating resilience. In March 2025, three cannabis stocks stand out for their growth potential and financial momentum: Ascend Wellness Holdings (AAWH), Cresco Labs (CRLBF), and Glass House Brands (GLASF). Each offers a unique footprint, retail strategy, and approach to profitability.
[Read More] 3 Marijuana Stocks For Cannabis Investors Who Speculate To Trade
Top U.S. Cannabis Stocks to Watch in March 2025: AAWH, CRLBF, and GLASF
- Ascend Wellness Holdings (OTC: AAWH)
- Cresco Labs (OTC: CRLBF)
- Glass House Brands (OTC: GLASF)
Ascend Wellness Holdings (AAWH)
Ascend Wellness Holdings is a vertically integrated multi-state cannabis operator with a strong presence across several key states. Its operations include cultivation, manufacturing, distribution, and retail, covering both adult-use and medical cannabis markets. Ascend focuses on states with limited license regimes, which provide tighter competition and higher barriers to entry. This approach allows the company to establish a meaningful footprint and strengthen its brand presence. The company’s largest retail presence is in Illinois and Michigan, with additional operations in Massachusetts, New Jersey, Ohio, and Pennsylvania. Currently, Ascend Wellness operates dozens of dispensaries across these markets. Its strategy emphasizes controlling more of the supply chain to secure margins and ensure product consistency. By blending cultivation and retail under one corporate umbrella, Ascend has built a foundation for long-term growth.
Latest financials
Ascend Wellness reported quarterly revenue of about $127 million from its cannabis operations. This figure represented a slight decline compared to the previous quarter but reflected ongoing stability. Year-over-year, revenue slipped by roughly ten percent, showing the effects of pricing pressures in competitive markets. The company posted an adjusted operating income close to break-even, reporting only a modest operating loss. Despite challenges, management has taken steps to reduce costs and improve operational efficiency. Debt remains on the balance sheet, but the company also maintains access to capital that can support further growth. Earnings per share have been negative, though analysts believe that upcoming regulatory changes could improve margins. If federal reform progresses and tax burdens ease, Ascend Wellness could leverage its strong retail presence to expand profitability.
[Read More] Best Canadian Cannabis Stocks to Watch for Growth and Opportunity
Cresco Labs (CRLBF)
Cresco Labs is one of the most recognized cannabis operators in the United States, known for its large retail and wholesale presence. The company’s flagship retail brand, Sunnyside, has become a familiar name in multiple states. Cresco operates approximately seventy-one Sunnyside dispensaries nationwide, making it one of the largest retail cannabis operators in the country. Its geographic footprint includes Illinois, Pennsylvania, Ohio, and other high-demand markets. Cresco also maintains operations in California, where it leverages its well-known product lines. Its strategy blends branded wholesale products with retail distribution, creating an integrated model that drives both scale and consumer reach. With a diverse retail network and strong wholesale channels, Cresco has positioned itself to capture growth from expanding adult-use markets.
Latest financials
Cresco Labs recently reported quarterly revenue of around $164 million. Gross profit came in near $83 million, translating into a healthy margin above 50 percent. The company’s adjusted EBITDA was roughly $41 million, yielding an EBITDA margin near 25 percent. Operating cash flow was positive at $9 million, reflecting improvements in cost control. However, Cresco posted a net loss of about $14 million, influenced by non-cash impairment charges linked to asset sales in California. Selling, general, and administrative expenses represented over 30 percent of revenue, a level management continues to monitor. To improve liquidity, Cresco refinanced its debt by securing a $325 million term loan, replacing older obligations. This move strengthens its balance sheet flexibility but still leaves pressure on long-term profitability. Despite near-term challenges, Cresco’s strong retail and wholesale model gives it solid growth potential in key states.
[Read More] 3 Marijuana Stocks To Buy In 2025 While The Sector Rebuilds
Glass House Brands (GLASF)
Glass House Brands is a California-focused cannabis operator with an emphasis on large-scale greenhouse cultivation. The company leverages its scale to achieve cost efficiencies while still maintaining craft-style quality under its Glass House Farms and PLUS brands. On the retail side, it operates under banners such as Farmacy, NHC, and The Pottery, which have become established in several parts of California. Glass House currently manages about ten dispensaries, giving it a strong direct-to-consumer platform in the state’s large cannabis market. This combination of cultivation and retail helps the company capture margins along the entire supply chain. Its focus on California positions it at the center of the largest U.S. cannabis market, though it also creates concentration risk compared to more diversified operators.
Latest financials
Glass House Brands delivered quarterly revenue of nearly $60 million, marking an increase of about 11 percent compared to the prior year. Gross margins improved to above 50 percent, reflecting better efficiency and production scale. Adjusted EBITDA was reported at more than $18 million, highlighting a profitable operating structure. The company also posted a positive operating cash flow of nearly $18 million, an important milestone for sustaining growth. Cash reserves, including restricted cash, totaled over $44 million, providing a buffer against industry volatility. Cultivation volumes reached more than 230,000 pounds, with production costs averaging just above $90 per pound. While labor constraints impacted some operations, management expects improvement in the upcoming quarters. With its scale, efficiency, and brand strength, Glass House remains well-positioned to benefit as California stabilizes and the broader U.S. industry matures.
[Read More] Cannabis Growth Outlook 2025: Best Ancillary Stocks to Watch This Week
U.S. Cannabis Penny Stocks to Watch as Federal Reform Moves Closer
By March 2025, these three cannabis companies will present distinct investment opportunities. Ascend Wellness offers a diversified state presence and potential upside if tax reform eases operating pressures. Cresco Labs combines retail and wholesale operations under a powerful brand but continues to face margin challenges. Glass House Brands offers a California-focused, efficiency-driven model that has demonstrated profitability despite regional headwinds.
As always, investors must weigh both risks and opportunities. Federal legalization remains uncertain, and pricing pressure continues to affect margins across the industry. However, the companies above are showing resilience and adaptability. With careful risk management and an eye on regulatory developments, these stocks could be strong contenders for cannabis investors in 2025.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
